{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:32:26Z","timestamp":1794277946104,"version":"4.9.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>COVID-19 exhibits diverse and systemic clinical symptoms, much like systemic autoimmune diseases, and there are notable similarities in the immune responses seen in both conditions. There are rare reports of ulcerative colitis and autoimmune hepatitis triggered by COVID-19 infection. Reported herein is a case of a previously healthy patient who was diagnosed with chronic colitis resembling ulcerative colitis, autoimmune pancreatitis, and suspected immune-mediated hepatitis (AIH-like hepatitis) 2\u2009months after a COVID-19 infection. A 33-year-old COVID-19-vaccinated male, presented with abdominal pain, nausea, and vomiting for 2\u2009days. He also had bloody diarrhea that persisted for 2\u2009months after recovering from a COVID-19 infection. A diagnosis of acute pancreatitis was confirmed by markedly elevated serum amylase and lipase and a CT scan of the abdomen. Colonoscopy and histopathology findings also confirmed a diagnosis of chronic colitis resembling ulcerative colitis (Mayo Endoscopy Subscore 3). Marked improvement in bloody diarrhea was observed within 72\u2009h of treatment with IV prednisolone. MRI of the abdomen performed due to an unresolved clinical picture of pancreatitis revealed a bulky pancreas showing delayed diffuse homogenous enhancement, findings possibly consistent with autoimmune pancreatitis. Investigation for elevated liver transaminases showed high titers of antinuclear antibodies and anti-smooth muscle (anti-actin) antibodies while viral hepatitis markers were negative. The patient had already been started on steroid therapy before the lab results were available, with rapid normalization of liver enzymes following treatment. A liver biopsy was not performed. The patient is currently on mesalazine 4 gr\/day, and azathioprine 100\u2009mg\/day \u2013 oral steroids had been tapered and discontinued. Seven months after the initial diagnosis, the patient remains symptom-free. A high level of suspicion for autoimmune disorders is required when assessing patients with a history of COVID-19 infection, although diagnostic pathways remain the same, with generally good response and remission rates to conventional treatment.<\/jats:p>","DOI":"10.3389\/fmed.2023.1013125","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T05:06:15Z","timestamp":1678943175000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Post-COVID-19 polyautoimmunity \u2013 Fact or coincidence: A case report"],"prefix":"10.3389","volume":"10","author":[{"given":"Ali Ibrahim","family":"Shorbagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmunhem","family":"Obaideen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majd","family":"Jundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"254319","DOI":"10.1155\/2012\/254319","article-title":"Introducing polyautoimmunity: secondary autoimmune diseases no longer exist","volume":"2012","author":"Rojas-Villarraga","year":"2012","journal-title":"Autoimmune Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.17235\/reed.2020.6677\/2019","article-title":"Association between autoimmune pancreatitis and ulcerative colitis: a report of 12 patients","volume":"112","author":"Almeida","year":"2020","journal-title":"Rev Esp Enferm Dig"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"otaa070","DOI":"10.1093\/crocol\/otaa070","article-title":"Extraintestinal manifestations and other comorbidities in ulcerative colitis and Crohn disease: a Danish Nationwide registry study 2003\u20132016","volume":"2","author":"Vadstrup","year":"2020","journal-title":"Crohn's Colitis 360"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1093\/ecco-jcc\/jjab055","article-title":"Validation of the \u201cinflammatory bowel disease-distribution, chronicity, activity [IBD-DCA] score\u201d for ulcerative colitis and Crohn\u2019s disease","volume":"15","author":"Lang-Schwarz","year":"2021","journal-title":"J Crohns Colitis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MPA.0000000000000261","article-title":"Prevalence and clinicopathological features of autoimmune pancreatitis in Japanese patients with inflammatory bowel disease","volume":"44","author":"Ueki","year":"2015","journal-title":"Pancreas"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/MCG.0b013e31827fd4a2","article-title":"The characteristics of ulcerative colitis associated with autoimmune pancreatitis","volume":"47","author":"Park","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.5009\/gnl210241","article-title":"Type 2 autoimmune pancreatitis: consensus and controversies","volume":"16","author":"Zen","year":"2022","journal-title":"Gut Liver"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/liv.15137","article-title":"Is it time to get rid of the biopsy mandate in adults with suspected autoimmune hepatitis? Lessons from the COVID-19 pandemic","volume":"42","author":"Shorbagi","year":"2022","journal-title":"Liver Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"International autoimmune hepatitis group. Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/s0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.jhepr.2020.100094","article-title":"Features and outcome of AIH patients without elevation of IgG","volume":"2","author":"Hartl","year":"2020","journal-title":"JHEP Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10620-010-1501-1","article-title":"Performance parameters of the conventional serological markers for autoimmune hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"102644","DOI":"10.1016\/j.jaut.2021.102644","article-title":"An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19","volume":"120","author":"Wang","year":"2021","journal-title":"J Autoimmun"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"100147","DOI":"10.1016\/j.jtauto.2022.100147","article-title":"A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases","volume":"5","author":"Wang","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"831849","DOI":"10.3389\/fimmu.2022.831849","article-title":"An autoantigen atlas from human lung HFL1 cells offers clues to neurological and diverse autoimmune manifestations of COVID-19","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.5152\/tjg.2021.20851","article-title":"Ulcerative colitis in a COVID-19 patient: a case report","volume":"32","author":"Ayd\u0131n","year":"2021","journal-title":"Turk J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1093\/ibd\/izab040","article-title":"SARS-CoV-2 as a trigger for De novo ulcerative colitis","volume":"27","author":"Imperatore","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1111\/liv.15044","article-title":"Autoimmune hepatitis triggered by COVID-19: a report of two cases","volume":"41","author":"Kaba\u00e7am","year":"2021","journal-title":"Liver Int"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/imj.15420","article-title":"Autoimmune hepatitis triggered by COVID-19","volume":"51","author":"Hong","year":"2021","journal-title":"Intern Med J"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e25783","DOI":"10.7759\/cureus.25783","article-title":"Severe ulcerative colitis as a complication of mild COVID-19 infection in a vaccinated patient","volume":"14","author":"Fonseca Mora","year":"2022","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.4240\/wjgs.v13.i6.574","article-title":"Acute pancreatitis and COVID-19: a literature review. World","volume":"13","author":"Correia de S\u00e1","year":"2021","journal-title":"J Gastrointest Surg"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1013125\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T05:06:17Z","timestamp":1678943177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1013125\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":23,"alternative-id":["10.3389\/fmed.2023.1013125"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1013125","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"article-number":"1013125"}}